跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 107 条关于
“DOACs”
全部
107
临床试验
84
药物
0
机构
0
资讯
23
28天前
Antiseizure Medication Choice Alters Stroke and Bleeding Risk in Epilepsy Patients on DOACs
去年
PRESTIGE-AF Trial: DOACs Show Mixed Results in Preventing Strokes for ICH Survivors with Atrial Fibrillation
2个月前
ONCO-DOAC BLEED Score: New Risk Stratification Tool for Bleeding Risk in Cancer-Associated VTE Patients on DOACs
去年
VarmX Receives FDA Fast Track Designation for VMX-C001 Anticoagulant Reversal Therapy
去年
Rivaroxaban Shows Kidney Protection Benefits in Atrial Fibrillation Patients with Advanced CKD
8个月前
VarmX and Rentschler Biopharma Expand Partnership for Phase III Development of Novel Coagulation Therapy VMX-C001
去年
Single Antiplatelet Therapy Shows Superior Safety Profile Over Dual Therapy After TAVR
去年
Closed Loop Medicine Secures US Patents for AI-Powered Precision Dosing in GLP-1 and DOAC Therapies
3年前
VarmX Secures €30M Series B2 Funding to Advance Anticoagulation Reversal Drug VMX-C001 Toward Pivotal Trial
去年
Abelacimab Shows Promise in Reducing Bleeding Risk for Atrial Fibrillation Patients
第 1 页,共 3 页
上一页
下一页